Featured
The vaccine, known as mRNA-1273,
was co-developed by the Cambridge, Massachusetts-based American biotechnology
company Moderna, Inc., and the National Institute of Allergy and Infectious
Diseases (NIAID), part of the National Institutes of Health. The trial, which
will be conducted at U.S. clinical research sites, is expecte...
Background: The Oxford Vaccine Group at the University of Oxford
are developing a new vaccine candidate for COVID-19, a chimpanzee adenovirus
vaccine vector called AZD1222 (previously ChAdOx1). The team has previously
developed a MERS vaccine.
In India, the candidate is being
jointly developed by the Serum Institute of India...
A diagram showing how the Oxford COVID-19 vaccine works. A chimpanzee
adenovirus is used in the ChAdOx1 viral vector, engineered to match the
SARS-CoV-2 spike protein.
The University of Oxford vaccine
is delivered via a chimpanzee virus, called the vaccine vector. The vector
contains the genetic code of t...
A vaccine in development by the
British-Swedish company AstraZeneca
and the University of Oxford is
based on a chimpanzee adenovirus called ChAdOx1.
Their Phase 1/2 trial revealed that the vaccine was safe, causing no severe
side effects. It raised antibodies against the coronavirus as well as other
immune defenses....
Background: CoronaVac (formerly PiCoVacc) is a formalin-inactivated
and alum-adjuvanted candidate vaccine. Results from animal studies showed
“partial or complete protection in macaques” exposed to SARS-CoV-2, according
to a paper published by researchers in the journal Science.
Study Design:
A Phase 1/2 trial enroll...
Chinese company Sinovac is
developing a vaccine based on inactivated Covid-19 particles. The vaccine has
shown a promising safety profile in the early stages of testing and is now
moving into Phase 3 trials in Brazil involving 9,000 volunteers. Already Phase
3 trials for Sinovac's CoronaVac began last week in Indonesia involving...
There is an assertion that the
Sinovac vaccine uses the "outdated" technology of inactivated whole viruses, and that
such "next generation" technologies as mRNA vaccines (NIH/Moderna) and live adenovirus vaccines into which Covid genes are introduced
(Oxford/Astra Zeneca) are preferable.
There is no scientific basis for
this...
An effective vaccine against
SARS-CoV-2 will save countless lives in Bangladesh and around the world. If the
Phase III trial of the Sinovac vaccine in Bangladesh demonstrates the vaccine
to be safe and protective, Sinovac has agreed to provide over 110,000 free vaccine doses for the
nation.
And more importantly, Sinovac has...
The Bangladesh Medical Research
Council or BMRC approved the phase 3 trial of Sinovac's vaccine candidate,
known as CoronaVac.
But due to the novelty of the process, health authorities are awaiting
approval from the government's top brass before flagging off the trials.
The International Centre for...
92 low- and middle-income economies eligible to get access to COVID-19 vaccines through Gavi COVAX Advance Market Commitment (AMC).
A new landmark collaboration
between Serum Institute of India (SII). the world’s largest vaccine manufacturer by volume, Gavi and the
Bill & Melinda Gates Foundation will accelerate the manufacture...
A COVID‑19 vaccine is a biotechnology product intended to provide acquired
immunity against coronavirus disease 2019 (COVID‑19).
Researchers around the world are
racing to develop a vaccine against Covid-19, with more than 170 candidate
vaccines now tracked by the World Health Organization (WHO). RemoveSponsored contentHow Vacci...
